2-(((6-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,4-dimethoxypyridine 1-oxide
95%
- Product Code: 41100
CAS:
953787-60-5
| Molecular Weight: | 399.3692 g./mol | Molecular Formula: | C₁₆H₁₅F₂N₃O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of proton pump inhibitors (PPIs). These inhibitors are widely used to treat gastrointestinal disorders such as acid reflux, peptic ulcers, and gastroesophageal reflux disease (GERD). The compound’s structure, featuring a benzimidazole core and sulfinyl group, plays a critical role in its ability to inhibit the H+/K+ ATPase enzyme in the stomach lining, thereby reducing acid production. Its specific modifications, such as the difluoromethoxy and dimethoxypyridine groups, enhance its stability and bioavailability, making it suitable for oral formulations. Additionally, its application extends to research and development for exploring new therapeutic agents targeting acid-related disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | ฿3,132.00 |
+
-
|
2-(((6-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,4-dimethoxypyridine 1-oxide
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of proton pump inhibitors (PPIs). These inhibitors are widely used to treat gastrointestinal disorders such as acid reflux, peptic ulcers, and gastroesophageal reflux disease (GERD). The compound’s structure, featuring a benzimidazole core and sulfinyl group, plays a critical role in its ability to inhibit the H+/K+ ATPase enzyme in the stomach lining, thereby reducing acid production. Its specific modifications, such as the difluoromethoxy and dimethoxypyridine groups, enhance its stability and bioavailability, making it suitable for oral formulations. Additionally, its application extends to research and development for exploring new therapeutic agents targeting acid-related disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :